Thursday, October 22, 2020

Tag: CoronaVirus Vaccine

Cheap Stocks to own before the Election

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

Your Week In Brief; These Small Caps Are Betting Big on...

Neuronetics’ flagship product is the NeuroStar Advanced Therapy System. NeuroStar uses transcranial magnetic stimulation (TMS) to create a pulsed MRI-strength magnetic field, which induces electrical currents designed to stimulate specific areas of the brain associated with mood.

Your Week In Brief; Big Trouble in Little Hollywood

The stock was in the green this week after releasing another denial of fraud allegations levied at the company courtesy of Wolfpack Research back in April. Citing in-person surveys of more than 1,500 people and Chinese credit reports of iQiyi’s VIEs and WFOEs, the short seller claimed that the Chinese entertainment platform overstated its user numbers and inflated its revenues in SEC filings by as much as 261.7% pre-IPO. Further, in 2019, Wolfpack estimated that iQiyi inflated revenue by 27% to 44%. Are they another Luckin Coffee? Maybe. But like Luckin, iQiyi can be both a liar and long-term winner. The SEC launched a probe into iQiyi and its parent company, Baidu (Nasdaq: BIDU).

Analysts are positive on these top Medical Technology and Healthcare stocks...

The new PetVivo medical device facility, primarily dedicated to the manufacture of its veterinary medical device for the treatment of osteoarthritis (OA), KUSH™ will serve as the primary location for PetVivo medical device operations, which provides manufacturing capabilities to produce up to 500,000 syringes of Kush that could generate over $100 million in revenue annually.

The Best Blockchain Stocks to Own

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 revenues which increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

COVID-19 Benefits Education Stocks

China Education Resources Inc. ("CHNUF”). CHNUF is perfectly poised to cater towards the intensified e-learning market demands which have arisen as a direct result of the COVID-19 pandemic.

M&A in Healthcare sparked by Covid-19

Johnson & Johnson (NYSE: JNJ) agreed to buy Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) for about $6.5 billion to expand in treatments for autoimmune diseases. And Sanofi (NASDAQ: SNY) said it would buy biotech company Principia Biopharma Inc., which develops treatments for multiple sclerosis and a range of autoimmune disorders, for $3.4 billion, as the French drug maker pivots toward innovative therapies to spur growth.”

Biotech Debt is Through the Roof; Where to find value

Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.

Your Week In Brief; I’m feeling Luckin

Most of us know the story of Luckin Coffee. In a nutshell, the company was supposed to be the Starbucks of China, giving the American coffee giant a run for its money on the Mainland. The Beijing-based company launched in 2017 and quickly grew its stores and pick-up locations to rival Starbucks (Nasdaq: SBUX) in China. The stock exploded in popularity. And then, it just exploded.

If you could only own 3 stocks, what would they be?

Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) and cite that it’s like owning the greatest fund out there, but with one exception… It has the best manager. Warren Buffett just turned 90 years old, BRK is down 8% YTD, and we all remember what happened when Steve Jobs passed. There will be a better opportunity to own BRK sometime in the future.